Health
From The Report: Mexico 2019
View in Online Reader

Although the country is moving closer to achieving its ambitious goal of universal health insurance coverage for all Mexican citizens, some obstacles still remain. The public health sector will require greater investment to meet key objectives set out in the National Health Plan 2019-24, while the question of how to address the rural-urban divide remains. Neither of these problems will likely be helped through increased budget cuts at the national level. The pharmaceutical and medical devices industries remain potential bright spots as multinational companies move their practices to Mexico to avoid import duties. Meanwhile, efforts to boost the private insurance penetration rate presents an investment opportunity that could help strengthen the industry. This chapter contains an interview with Rodrigo Puga, Country Manager, Pfizer.

Articles from this Chapter

Overview

With great care: Achieving universal access remains a government goal, while key industries prepare for significant expansion
OBG
plus

Steady progress has been made in the expansion and modernisation of Mexico’s health care sector in recent years, though there remains room for improvement. According to the 2017 National Survey of Employees and Social Security published by Mexico’s National Institute of Statistics and Geography, the percentage of the population covered by health services increased from 59.9% in 2009 to 82.7% in 2017. This was partly due to the introduction of the People’s Health Insurance Scheme (Seguro…

Analysis

Best medicine: Streamlining government procedures to ensure global firms continue to invest in the pharmaceuticals market
OBG
plus

Major global firms continue to invest in Mexico’s pharmaceutical industry. In 2017, 20 of the world’s top-25 pharmaceutical giants were active in the country, and 22.7% of total health spending went towards the pharmaceutical industry, according to the OECD. That same year, Mexico was the second-largest pharmaceutical market in Latin America and ranked 15th in the world, contributing around 0.5% of the country’s GDP, according to multinational professional services network KPMG. Looking…

Interview

Poised for growth: Rodrigo Puga, Country Manager, Pfizer, on the importance of sustained innovation investment in pharmaceuticals
OBG
plus

Interview:Rodrigo Puga What are the key themes of the government’s national health care plan, and what does this mean for the pharmaceuticals industry? RODRIGO PUGA: Generating savings, improving transparency and eliminating corruption are the defining goals of the national health plan. It is expected that these efforts will free up resources and enable the provision of better medications and treatments to the public. The budget will increase each year until 2025. Currently, Mexico invests…

Analysis

Slow and steady: The adoption of digital health systems continues with the help of private sector encouragement
OBG
plus

Several policies aimed at developing a digital health care system in Mexico have seen the costs associated with bureaucracy decrease significantly. According to a policy brief published by the OECD in 2018, the simplification of government procedures across all sectors has seen the cost of administrative burdens decrease from 4.3% of GDP in 2012 to 2.7% in 2017. The health care sector stands to gain from state digitalisation efforts, especially as the administration of President Andrés Manuel…

Overview

Investing in health: Advancing medical technology leads to improved patient care and cost savings
OBG
plus

Rising health care costs, ageing populations and changing lifestyles in emerging economies are stoking demand for medical technology (medtech) solutions. These entail not just smart devices that remotely monitor and transmit biometric data, but any instance of technology that helps to deliver health services. These initiatives are happening everywhere, but there are significant differences in the speed and scale of medtech adoption across emerging markets. UBS Investment Bank estimates that the emerging markets health sector will grow 6.3% annually over the next decade – double the speed of developed markets – as governments make…

Overview

Investing in health: Advancing medical technology leads to improved patient care and cost savings
OBG
plus

Rising health care costs, ageing populations and changing lifestyles in emerging economies are stoking demand for medical technology (medtech) solutions. These entail not just smart devices that remotely monitor and transmit biometric data, but any instance of technology that helps to deliver health services. These initiatives are happening everywhere, but there are significant differences in the speed and scale of medtech adoption across emerging markets. UBS Investment Bank estimates that the emerging markets health sector will grow 6.3% annually over the next decade – double the speed of developed markets – as governments make…